[1]
Popa, S. 2022. New approaches in modulating the GLP-1/GLP-2 AXIS: link between metabolic diseases and inflammatory bowel disease. Romanian Journal of Diabetes Nutrition and Metabolic Diseases. 29, 3 (Sep. 2022), 376-380.